Ending the coronavirus pandemic is not only about the technical issue of vaccine development. The challenge is multidimensional, involving a global proprietary pharmaceutical system and an exclusive, nationalist tendency in wealthy, prosperous states.
Topic:
Nationalism, Vaccine, COVID-19, Health Crisis, and Pharmaceuticals